Stinging nettle can distinguish a broader prostate formula from a basic one, but the root-versus-leaf difference matters more than many labels suggest.
By Dr. Marcus Reed, MD · Last Updated: July 23, 2026
What the evidence says: Stinging nettle (Urtica dioica) is used for BPH primarily as a root extract, where lignans and sterols appear to affect sex-hormone-binding globulin and prostate cell activity. A six-month randomized double-blind placebo-controlled crossover trial in 620 men found it significantly improved IPSS scores and urine flow. The key practical point: nettle root carries the evidence, while nettle leaf — a different plant part with different chemistry — does not.
Nettle is uncommon in basic prostate formulas, so its inclusion often signals a broader ingredient approach. It also carries an important technical distinction that most supplement content gets wrong, and that distinction happens to be directly relevant to how you should read the Prostate 911 label. This page covers the botany, the mechanism, the trial evidence, the root-versus-leaf question, and safe use.
Urtica dioica is a herbaceous perennial found across Europe, Asia, North Africa and North America — the same plant whose leaves deliver the familiar sting on contact, caused by formic acid and histamine in fine hollow hairs. Once cooked or dried, the sting disappears entirely, and nettle has a long history as both food and medicine.
For prostate purposes the relevant part is the root, not the leaf. That matters because the two have quite different phytochemistry. Nettle root contains lignans — notably (-)-3,4-divanillyltetrahydrofuran — along with sterols including beta-sitosterol, polysaccharides, and lectins. Nettle leaf is richer in flavonoids, chlorophyll, minerals and the compounds associated with its traditional use for allergic rhinitis and joint pain.
European phytotherapy has used standardized nettle root extract for lower urinary tract symptoms for decades, often in fixed combination with saw palmetto. That combination has its own body of comparative research, including trials measuring it against finasteride.
The most-cited mechanism. Nettle root lignans appear to bind sex-hormone-binding globulin (SHBG), the protein that transports testosterone and estradiol through the bloodstream. By occupying binding sites, they may influence how much free hormone reaches prostate tissue and how SHBG interacts with prostate cell membranes. This is a different point of intervention from saw palmetto's enzyme inhibition, which is one reason the two are frequently paired.
Laboratory work on nettle root extracts and their steroidal components found effects on the Na+/K+-ATPase of benign prostatic hyperplasia tissue (PMID 7510891). This enzyme is involved in cellular ion transport and metabolism, and inhibiting it may suppress prostate cell proliferation. The finding is mechanistic rather than clinical, but it is one of the more specific pieces of laboratory evidence in the phytotherapy literature.
Nettle root components have shown activity against both aromatase — the enzyme converting testosterone to estradiol — and, in some preparations, 5-alpha-reductase. Given that the shifting androgen-to-estrogen ratio with age appears to sensitise prostate tissue to DHT's growth signal, aromatase activity is a plausible and somewhat distinctive contribution.
Nettle polysaccharides and caffeic malic acid inhibit cyclooxygenase and lipoxygenase pathways. This contributes to the inflammatory arm of BPH management and overlaps with pygeum's mechanism.
The strongest single piece of evidence is a six-month double-blind, placebo-controlled, randomized partial crossover trial of Urtica dioica in 620 patients with lower urinary tract symptoms secondary to BPH. Patients were evaluated on International Prostate Symptom Score, maximum urinary flow rate, post-void residual volume, serum PSA, testosterone levels and prostate size (PMID 16635963). The trial reported significant improvement in symptom scores and flow measures in the nettle group compared with placebo.
A 620-patient randomized crossover trial is a substantial study by phytotherapy standards, considerably larger than most supplement-ingredient research.
European work has tested standardized nettle root extract over extended periods. A one-year randomized, double-blind, placebo-controlled multicentre study gave 246 men either 459 mg daily of dry nettle root extract or placebo, following them for twelve months on IPSS scores. Nettle-group scores fell by an average of around six points against slightly over four in the placebo arm — a real but modest difference, and a reminder of how high placebo response runs in BPH trials.
Nettle root is frequently studied combined with saw palmetto, and the combination has more supporting evidence than nettle alone. Comparative work has measured fixed sabal-and-urtica combinations against finasteride, with some trials finding no statistically significant difference in symptom outcomes over six months — though such equivalence findings need cautious reading, since a small trial failing to detect a difference is not the same as demonstrating there is none.
Much of the nettle literature is European, older, and involves proprietary standardized extracts not identical to what appears in American supplements. Study quality is variable. And as with all BPH phytotherapy, the placebo response is high enough that modest true effects are difficult to isolate.
This deserves its own section because it is where most supplement content — and some supplement labels — goes wrong.
Essentially all of the positive BPH research on Urtica dioica used root extract. The Safarinejad crossover trial, the German multicentre studies, the sabal-urtica combination trials, the Na+/K+-ATPase laboratory work: root throughout. The lignans and sterols associated with prostate activity are concentrated there.
Nettle leaf has its own legitimate uses — allergic rhinitis, joint pain, as a mineral-rich food — but it does not carry the prostate evidence. The two are not interchangeable, and a product listing nettle leaf while citing nettle root research is, in effect, citing evidence for a different ingredient.
The Prostate 911 label specifies stinging nettle leaf powder at 20 mg. That is a genuine gap between the citation and the ingredient, and it is the kind of detail worth knowing when you compare formulas. It is not unique to this product — leaf is cheaper and more widely available than standardized root extract, so it appears in many blends — but a formula using standardized nettle root at a meaningful dose is better aligned with the research.
For context on dose: the German trial used 459 mg of dry root extract daily. Twenty milligrams of leaf powder is a different proposition entirely.
Typical studied doses of nettle root extract fall between 300 and 600 mg daily, often split across two doses. The German long-term trial used 459 mg daily. Combination products pairing nettle root with saw palmetto typically use 120-320 mg of each.
As with the rest of this category, nettle works gradually. Trials run for three to twelve months, and the German study's endpoint was at one year. Expect the same eight-to-twelve-week evaluation window that applies to saw palmetto and beta-sitosterol, with the understanding that longer use may continue to help.
Nettle is generally well tolerated. Reported effects are mild and uncommon:
Nettle root is best understood as a genuine third pillar alongside saw palmetto and beta-sitosterol, rather than a filler ingredient. It intervenes at a different point — SHBG interaction and aromatase activity rather than direct 5-alpha-reductase inhibition — which is exactly why the European combination products pair it with saw palmetto rather than choosing between them.
Its presence on an ingredient list is a reasonable signal that a formula has been designed rather than assembled. Its absence from cheap saw-palmetto-only products is one of the clearest arguments for spending more. But the root-versus-leaf point matters: nettle on a label is only as meaningful as the plant part and dose behind it.
As always, this sits within limits. Nettle manages symptoms in mild-to-moderate BPH. It does not resolve retention, treat infection, or substitute for evaluation. If you have blood in the urine, cannot urinate, have fever with urinary symptoms, or your symptoms changed suddenly, that needs a doctor rather than a botanical. See our symptom guide for the full warning-sign list.
Nettle has a broader traditional and clinical footprint than most prostate ingredients, and knowing it helps you interpret what you are buying.
Nettle leaf is used for hay fever, and this is where leaf preparations have their own evidence. A randomized double-blind placebo-controlled trial of nettle root extract for allergic rhinitis found improvement in clinical symptom severity, though placebo showed similar effects on several measures — a common pattern in allergy research. Mechanistically the interest is in antihistamine and mast-cell stabilising activity.
Topical nettle has been studied for osteoarthritis, and oral preparations have been examined for inflammatory joint conditions. The proposed mechanism overlaps with the prostate work — cyclooxygenase and lipoxygenase inhibition via polysaccharides and caffeic malic acid.
Nettle has shown modest effects on both in some studies. This is more relevant as a caution than a benefit: if you take medication for diabetes or hypertension, an ingredient nudging those parameters is something your doctor should know about.
Cooked nettle leaf is a genuine food, rich in iron, calcium, vitamin K and vitamin A. Nettle soup and nettle tea are traditional across much of Europe. This is entirely separate from the prostate application and involves no meaningful dose of the root compounds.
Placing nettle accurately against its shelf-mates:
The overall picture is that nettle root is not interchangeable with anything else on the list. That is the argument for its inclusion in a broad formula, and the argument against products that leave it out to save cost.
Used this way, nettle is a sensible component of a first-line approach for mild-to-moderate urinary symptoms. It is not a treatment, and it will not compensate for skipping an evaluation when something is wrong.
Key takeaway: Nettle root — not leaf — carries the BPH evidence, including a 620-man randomized crossover trial and year-long German studies at around 459 mg daily. It works through SHBG and aromatase pathways rather than direct 5-alpha-reductase inhibition, making it complementary to saw palmetto. Check which plant part your product uses.
Saw palmetto, beta-sitosterol, pygeum, nettle and pumpkin seed in one daily formula. 90-day money-back guarantee.
Order from Official Website